Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815834) titled 'FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Fudan University
Condition:
Colon Rectal Cancer Adenocarcinoma
Peritoneal (Metastatic) Cancer
Second-line Treatment
Radiation Therapy
Immunotherapy
Intervention:
Drug: Second-Line Chemotherapy
Radiation: Radiation Therapy
Recruitment Status: Not recruiting
Phase:...